SUVfdg: A standard-uptake-value (SUV) body habitus normalizer specific to fluorodeoxyglucose (FDG) in humans

Beattie, BJ; Akhurst, TJ; Augensen, F; Humm, JL

Author(s): Beattie, BJ; Akhurst, TJ; Augensen, F; Humm, JL;
Details: Publication Year 2022,Volume 17,Issue #4,Page e0266704
Journal Title: PLoS One
Publication Type: Research article
Abstract: PURPOSE: To devise a new body-habitus normalizer to be used in the calculation of an SUV that is specific to the PET tracer 18F-FDG. METHODS: A cohort of 481-patients was selected for analysis of 18F-FDG uptake into tissues unaffected by their disease. Among these, 65-patients had only brain concentrations measured and the remaining 416 were randomly divided into an 86-patient test set and a 330-patient training set. Within the test set, normal liver, spleen and blood measures were made. In the training set, only normal liver concentrations were measured. Using data from the training set, a simple polynomial function of height and weight was selected and optimized in a fitting procedure to predict each patient's mean liver %ID/ml. This function, when used as a normalizer, defines a new SUV metric (SUVfdg) which we compared to SUV metrics normalized by body weight (SUVbw), lean-body mass (SUVlbm) and body surface-area (SUVbsa) in a five-fold cross-validation. SUVfdg was also evaluated in the independent brain-only and whole-body test sets. RESULTS: For patients of all sizes including pediatric patients, the normal range of liver 18F-FDG uptake at 60 minutes post injection in units of SUVfdg is 1.0 +/- 0.16. Liver, blood, and spleen SUVfdg in all comparisons had lower coefficients of variation compared to SUVbw SUVlbm and SUVbsa. Blood had a mean SUVfdg of 0.8 +/- 0.11 and showed no correlation with age, height, or weight. Brain SUVfdg measures were significantly higher (P<0.01) in pediatric patients (4.7 +/- 0.9) compared to adults (3.1 +/- 0.6). CONCLUSION: A new SUV metric, SUVfdg, is proposed. It is hoped that SUVfdg will prove to be better at classifying tumor lesions compared to SUV metrics in current use. Other tracers may benefit from similarly tracer-specific body habitus normalizers.
Keywords: Adult; Body Height; Body Surface Area; Child; Cohort Studies; *Fluorodeoxyglucose F18; Humans; *Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals
Department(s): Cancer Imaging
PubMed ID: 35446848
Publisher's Version: https://doi.org/10.1371/journal.pone.0266704
Open Access at Publisher's Site: https://doi.org/10.1371/journal.pone.0266704
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2024-10-04 07:33:08

Last Modified: 2024-10-04 07:34:42